Literature DB >> 27440845

Perforation of the bowel due to cytomegalovirus infection in a man with AIDS: surgery is not always necessary!

Katie Tharshana Yoganathan1, Andrew Roger Morgan2, Kathir G Yoganathan3.   

Abstract

Cytomegalovirus (CMV) infection is the most common viral opportunistic infection in immunocompromised patients and is a rare cause of bowel perforation. It invariably requires surgical intervention and is often fatal. We report a 50-year-old Caucasian man with AIDS, presented 3 weeks after developing abdominal pain and distension. He was treated for CMV retinitis in the past. His adherence to antiretroviral therapy was poor. Examination revealed a recurrence of active CMV retinitis. His abdomen was tender and distended. The plain X-ray of the abdomen revealed a double wall sign (Rigler's sign), indicating pneumoperitoneum due to the bowel perforation. The upper endoscopy was normal. His CD4 count was 30 cells/mm(3) He was treated with cidofovir infusion. He made a full recovery, without requiring any form of surgery. However, he died of adult respiratory distress syndrome 14 months later, due to iatrogenic acute pancreatitis. 2016 BMJ Publishing Group Ltd.

Entities:  

Mesh:

Year:  2016        PMID: 27440845      PMCID: PMC4964158          DOI: 10.1136/bcr-2015-214196

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  11 in total

1.  Rigler's sign in a patient with massive pneumoperitoneum.

Authors:  S Milanchi; D Wood
Journal:  Emerg Med J       Date:  2006-11       Impact factor: 2.740

2.  Ileal perforation caused by cytomegalovirus infection in a critically ill adult.

Authors:  R S Chamberlain; S Atkins; N Saini; J C White
Journal:  J Clin Gastroenterol       Date:  2000-06       Impact factor: 3.062

3.  Surgery in patients with acquired immunodeficiency syndrome.

Authors:  G Robinson; S E Wilson; R A Williams
Journal:  Arch Surg       Date:  1987-02

Review 4.  Intestinal perforation due to cytomegalovirus infection in patients with AIDS.

Authors:  H B Kram; W C Shoemaker
Journal:  Dis Colon Rectum       Date:  1990-12       Impact factor: 4.585

5.  Toxic megacolon in cytomegalovirus colitis.

Authors:  J J Orloff; R Saito; S Lasky; H Dave
Journal:  Am J Gastroenterol       Date:  1989-07       Impact factor: 10.864

Review 6.  Radiologic diagnosis of gastrointestinal perforation.

Authors:  Stephen E Rubesin; Marc S Levine
Journal:  Radiol Clin North Am       Date:  2003-11       Impact factor: 2.303

7.  Long-term suppressive therapy for pulmonary aspergilloma in an immunocompromised man with AIDS. Is it always necessary?

Authors:  K Yoganathan
Journal:  Int J STD AIDS       Date:  2009-06       Impact factor: 1.359

8.  In situ hybridization and immunohistochemical analysis of cytomegalovirus-associated ileal perforation.

Authors:  R M Genta; I Bleyzer; T R Cate; A K Tandon; B Yoffe
Journal:  Gastroenterology       Date:  1993-06       Impact factor: 22.682

9.  Retinal and gastrointestinal disease due to cytomegalovirus in patients with the acquired immune deficiency syndrome: prevalence, natural history, and response to ganciclovir therapy.

Authors:  M A Jacobson; J J O'Donnell; D Porteous; H R Brodie; D Feigal; J Mills
Journal:  Q J Med       Date:  1988-06

10.  Cytomegalovirus colitis presenting as hematochezia and requiring resection.

Authors:  A Escudero-Fabre; O Cummings; J K Kirklin; R C Bourge; J S Aldrete
Journal:  Arch Surg       Date:  1992-01
View more
  2 in total

1.  Comparative analysis of cytomegalovirus retinitis and microvascular retinopathy in patients with acquired immunodeficiency syndrome.

Authors:  Chao Chen; Chun-Gang Guo; Li Meng; Jing Yu; Lian-Yong Xie; Hong-Wei Dong; Wen-Bin Wei
Journal:  Int J Ophthalmol       Date:  2017-09-18       Impact factor: 1.779

2.  Clinical Features of Cytomegalovirus Retinitis in HIV Infected Patients.

Authors:  Yang Tang; Jianjun Sun; Taiwen He; Yinzhong Shen; Li Liu; Corklin R Steinhart; Jun Chen; Tangkai Qi; Zhenyan Wang; Wei Song; Renfang Zhang
Journal:  Front Cell Infect Microbiol       Date:  2020-04-07       Impact factor: 5.293

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.